RESEARCH FRONTIERS INC quarterly report, Q3 FY2023

Research Frontiers Incorporated — 2023 Q3 Form 10-Q

Business Context and Reporting Period

The filing covers the three and nine months ended September 30, 2023. Research Frontiers develops and licenses suspended particle device (SPD) light-control technology for automotive, architectural, marine, aerospace, appliance, eyewear and other applications. The Company operates as a single business segment and primarily earns licensing and royalty fee income.

Financial Performance and Position

MetricThree Months Ended September 30Nine Months Ended September 30
Fee income$164,146 in 2023 versus $150,443 in 2022$597,362 in 2023 versus $409,783 in 2022
Operating expenses$542,635 versus $487,476$1,695,129 versus $1,770,414
Research and development$135,319 versus $149,156$430,150 versus $444,413
Operating loss$513,808 versus $486,189$1,527,917 versus $1,805,044
Net investment income$41,642 versus $2,460$99,463 versus a $48,871 loss
Net loss$472,166, or $0.01 per share, versus $483,729, or $0.02 per share$1,428,454, or $0.04 per share, versus $1,853,915, or $0.06 per share

For the nine-month period, fee income increased approximately 46% year over year, while the net loss decreased approximately 23%. The Company remained substantially unprofitable: nine-month operating loss was approximately 256% of fee income, and third-quarter operating loss was approximately 313% of fee income.

At September 30, 2023, cash and cash equivalents were $524,985 and marketable securities were $2,499,625, for total cash and marketable securities of approximately $3.0 million. Working capital was approximately $3.6 million, total assets were $4.2 million, shareholders’ equity was $3.9 million, and accumulated deficit was $123.8 million.

The Company had no debt. Liabilities primarily consisted of operating lease obligations, with total lease liabilities of approximately $317,805. Operating lease expense was approximately $163,000 for the first nine months.

Net cash used in operating activities was $1,746,317 for the first nine months of 2023, compared with $1,615,566 in the prior-year period. Investing activities used $2,444,116, primarily reflecting purchases of marketable securities, and financing activities provided $484,502 from warrant exercises. Cash and cash equivalents declined by $3,705,931 during the period.

Material Changes Versus the Prior Comparable Period

  • Fee income increased by $13,703, or approximately 9%, in the third quarter and by $187,579, or approximately 46%, for the first nine months, primarily from higher automotive royalties.
  • Aircraft-related revenue partially offset the third-quarter automotive improvement.
  • Third-quarter operating expenses increased $55,159, primarily because of $105,000 of higher bad-debt expense, partially offset by lower legal and professional fees and payroll costs.
  • Nine-month operating expenses decreased $75,285, reflecting lower bad-debt, patent, legal, professional, investor-relations and foreign-tax costs, partly offset by higher payroll and compensation costs.
  • Research and development expense decreased modestly in both the quarter and nine-month period.
  • Investment income improved materially because of higher interest rates and market-value changes in marketable securities; the prior-year nine-month period included a loss on securities sales.
  • The Company received $484,502 from the exercise of warrants covering 358,891 shares. Shares outstanding increased to 33,509,287 at September 30, 2023, from 33,150,396 at December 31, 2022.

Guidance, Outlook, Risks and Unusual Items

Management expects the automotive market to remain the largest source of royalty income and anticipates additional royalty opportunities from new automobile and aircraft models, marine applications, trains, museums and larger architectural projects. Management also expects production efficiencies and lower pricing per square foot to support adoption, although these statements are forward-looking and not guaranteed.

The Company estimates a quarterly cash-flow shortfall of approximately $200,000 to $250,000 over the next 12 months, after considering expected additional royalties and excluding nonrecurring cash expenses. The filing states that current resources should support operations for at least the next 12 months; the MD&A additionally states that, under its assumptions, working capital could support more than five years of operations. The Company may reduce expenses or seek additional equity financing if needed, but there is no assurance that financing will be available on acceptable terms.

  • The Company has incurred recurring losses since inception and has not generated sufficient licensing revenue to fund operations.
  • Royalty income is concentrated among a small number of licensees and is heavily influenced by automotive production volumes, OEM adoption, vehicle configurations, pricing, exchange rates and timing of royalty payments.
  • Four licensees accounted for approximately 29%, 20%, 20% and 18% of nine-month fee income. Three licensees accounted for approximately 47%, 19% and 19% of third-quarter fee income.
  • Royalty receivables were $721,244 net of reserves totaling $1,253,450. The Company recorded $95,000 of bad-debt expense during the first nine months.
  • One license agreement has $88,000 of remaining performance-obligation revenue expected to be recognized through December 31, 2024, subject to the agreement’s terms.
  • The Chairman and CEO of Gauzy, a licensee, joined the Company’s Board effective June 4, 2023. Gauzy represented less than 5% of fee income and royalty receivables as of the reporting date.
  • Net operating loss and other deferred-tax benefits remain fully reserved because management believes realization is not more likely than not.
  • Management concluded that disclosure controls were effective and reported no material changes to internal control over financial reporting.

Investor Verification Points

  • Verify the sustainability and timing of increased automotive royalty revenue and the expected launch schedule for additional licensed models.
  • Reconcile the filing’s liquidity statements, including the approximately $3.0 million of cash and marketable securities, the projected $200,000–$250,000 quarterly cash shortfall, and the differing “at least 12 months” and “more than five years” liquidity assertions.
  • Monitor royalty-receivable collections, the $1.25 million allowance for doubtful accounts and customer concentration.
  • Review potential future equity financing needs, outstanding warrants and options, and related dilution risk.
  • Assess the related-party implications and royalty economics of the Gauzy licensing relationship following its executive’s appointment to the Board.